Trial intelligence / Profile preview

Prophylactic intravenous aminophylline for prevention of post-spinal anesthesia shivering after lower limb orthopedic surgery

IRCT20211107052990N1Phase 3Completed

Sponsor
Alborz University of Medical Sciences
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of aminophylline in postanesthetic shivering (PAS) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Shivering, Body temperature and 1 more. Started Dec 2021; status: completed.

02

Drugs

aminophylline
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20211107052990N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211107052990N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call